TITLE

Indacaterol Inhalation Powder (Arcaptaâ„¢ Neohaler)

AUTHOR(S)
Elliott, William T.; Chan, James
PUB. DATE
October 2011
SOURCE
Internal Medicine Alert;10/15/2011, Vol. 33 Issue 19, p149
SOURCE TYPE
Periodical
DOC. TYPE
Abstract
ABSTRACT
An abstract related to the use of indacaterol in the treatment of chronic obstructive pulmonary disease (COPD), is presented.
ACCESSION #
69591482

 

Related Articles

  • New metered-dose inhaler for bronchospasm associated with COPD.  // Modern Medicine;Jan97, Vol. 65 Issue 1, p48 

    Reports on the US Food and Drug Administration's (FDA) approval of a combination of the anticholinergic bronchodilator ipratropium bromide and the beta2-adrenergic bronchodilator albuterol sulfate for patients with chronic obstructive pulmonary disease.

  • Respiratory remedy. R.M.D. // Cortlandt Forum;11/25/96, Vol. 9 Issue 11, p66 

    Features the use of various bronchodilators for the treatment of obstructive pulmonary diseases. Ratio of drugs to be used; Concern on the effects of atropine on the lungs.

  • Non-invasive ventilation for acute exacerbations of chronic obstructive pulmonary disease. Baldwin, David R.; Allen, Martin B. // BMJ: British Medical Journal (International Edition);1/18/97, Vol. 314 Issue 7075, p163 

    Editorial. Describes a treatment process for acute exacerbation of chronic obstructive pulmonary disease. Use of non-invasive positive pressure ventilation; Summary of the result of the study to determine the efficacy of the treatment procedure; Predictors of success of the treatment.

  • Pulmonary medicine. Pingleton, Susan K. // JAMA: Journal of the American Medical Association;6/19/96, Vol. 275 Issue 23, p1849 

    Discusses some of the advances in therapy for chronic obstructive pulmonary disease (COPD) that have occurred in 1995. The expansion of the evaluation of medical therapy for airflow obstruction; Improvement of ventilation therapy; The evaluation of new surgical approaches for treatment of...

  • Correction: Pulsed moxifloxacin for the prevention of exacerbations of chronic obstructive pulmonary disease: a randomized controlled trial. Sethi, Sanjay; Jones, Paul W.; Theron, Marlize Schmitt; Miravitlles, Marc; Rubinstein, Ethan; Wedzicha, Jadwiga A.; Wilson, Robert // Respiratory Research;2010, Vol. 11, p88 

    A correction to the article "Pulsed moxifloxacin for the prevention of exacerbations of chronic obstructive pulmonary disease: a randomized controlled trial" that was published in a previous issue is presented.

  • Pharmacological Treatment in Acute Exacerbations of Chronic Obstructive Pulmonary Disease. Ikeda, A.; Nishimura, K.; Izumi, T. // Drugs & Aging;1998, Vol. 12 Issue 2, p129 

    Exacerbations of chronic obstructive pulmonary disease (COPD) are usually treated with bronchodilator therapy, glucocorticoids and antibiotics. However, there are few experimental data on the effects of these agents in patients with acute COPD. A β-adrenoceptor agonist is usually given first...

  • Call for trial volunteers with serious respiratory diseases.  // Australian Journal of Pharmacy;Aug2010, Vol. 91 Issue 1083, p30 

    The article reports on the request in encouraging pharmacists to participate in three international studies concerning the treatment for patients with chronic obstructive pulmonary disease (COPD) in Australia.

  • Therapeutic strategies that work. Pennachio, Dorothy; Celli, Bartolome R.; Cosentino, Anthony; Fiel, Stanley; Petty, Thomas L. // Patient Care;3/15/1997, Vol. 31 Issue 5, p100 

    Discusses the use of therapeutic strategies for the treatment of chronic obstructive pulmonary disease (COPD). How smoking cessation and oxygen therapy can improve survival; Description of the goals of the treatment; Details on therapeutic treatments; Effectiveness of the strategies. INSETS:...

  • Tiotropium Respimat as safe as Handihaler.  // Reactions Weekly;9/28/2013, Issue 1471, p3 

    The article focuses on the Tiotropium Safety and Performance in Respimat (TIOSPIR) study as of September 2013 which revealed that tiotropium respimat had a similar safety profile to that of tiotropium handihaler taken once daily in patients with chronic obstructive pulmonary disease.

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics